Stomach Neoplasms clinical trials

Explore recruiting stomach neoplasms clinical trials.

Recruiting stomach neoplasms studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stomach Neoplasms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors (FiREBOLT)

Germany, Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Stomach Neoplasms trials by city

Stomach Neoplasms in Toronto Stomach Neoplasms in Vancouver Stomach Neoplasms in Montreal Stomach Neoplasms in Calgary Stomach Neoplasms in Edmonton Stomach Neoplasms in Ottawa Stomach Neoplasms in Winnipeg Stomach Neoplasms in Quebec City Stomach Neoplasms in Hamilton Stomach Neoplasms in Kitchener Stomach Neoplasms in London Stomach Neoplasms in Halifax Stomach Neoplasms in New York Stomach Neoplasms in Los Angeles Stomach Neoplasms in Chicago Stomach Neoplasms in Houston

Stomach Neoplasms clinical trials

Recruiting stomach neoplasms studies right now

Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

Robotic Gastrectomy With 5th Arm

QL1706 Combined With SOX Used in Theperioperative Treatment

AB122 Platform Study

Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma

Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma

Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence

Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Also recruiting in Europe

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors (FiREBOLT)

Stomach Neoplasms trials by city

Other conditions